Clinical Trial Update: Effect of Melatonin on Oxidative Stress Parameters in Levodopa-Treated Parkinson's Disease Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating whether melatonin affects oxidative stress parameters in levodopa-treated Parkinson's disease patients, currently enrolling b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Bangladesh Medical University | Conditions: Parkinson Disease | Phase 2 | Status: ENROLLING_BY_INVITATION